USPTO serial 79168971
Serial No. 79168971
Reviewed by CopyMark Law Group
Reg. 4975416Status 404
- Filing date
- Status date
- Registration date
- Jun 14, 2016
- Examiner
- MILTON, PRISCILLA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79168971?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bryce J. Maynard
Bryce J. Maynard Buchanan Ingersoll & Rooney PC1737 King Street, Suite 500Alexandria, VA 22314UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations for the testing, diagnosis, prevention or treatment of drug dependency, substance addiction, poisoning, overdose, envenomation, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, polyposis, sinusitis, non-allergic rhinitis, obesity, cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, gynaecological, oncological, hepatological, ocular, haemostasis, obstetric, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, renal system, urinary tract, otolaryngology, psychiatric, fertility and immune system related diseases and disorders | SECTION 71 - CANCELLED | — |
| 042 | Scientific research for medical purposes in the fields of allergies, drug dependency, substance addiction, autoimmune disease, poisoning, overdose, envenomation transplant rejection, immunodeficiency disorders, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, polyposis, sinusitis, non-allergic rhinitis, obesity, cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, gynaecological, oncological, hepatological, ocular, haemostasis, obstetric, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, renal system, urinary tract, otolaryngology, psychiatric, fertility and immune system related diseases and disorders; medical and pharmacological research services in the fields of allergies, drug dependency, substance addiction, autoimmune disease, poisoning, overdose, envenomation, transplant rejection, immunodeficiency disorders, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, polyposis, sinusitis, non-allergic rhinitis, obesity, cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, gynaecological, oncological, hepatological, ocular, haemostasis, obstetric, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, renal system, urinary tract, otolaryngology, psychiatric, fertility and immune system related diseases and disorders; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the fields of pharmaceutical and clinical trials; conducting clinical trials for others; information, advisory and consultancy services relating to the aforesaid | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 11, 2025 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jul 11, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Oct 9, 2023 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 16, 2023 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 16, 2023 | INPC | INVALIDATION PROCESSED | — |
| Aug 30, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 30, 2022 | C71T | CANCELLED SECTION 71 | — |
| Dec 4, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 14, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 25, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 13, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 19, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 19, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 14, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 14, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 29, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 29, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 25, 2016 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 9, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 9, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 9, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 23, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 4, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 4, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 4, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 22, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 4, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 4, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 4, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 3, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 31, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 27, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 27, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 22, 2015 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jul 16, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |